Certain Types of Iron Oxide Nanoparticles are Not Suited to Passively Target Inflammatory Cells that Infiltrate the Brain in Response to Stroke
Christoph Harms(Charité - Universitätsmedizin Berlin), Tracy D. Farr(University of Nottingham), Eyk Schellenberger(Harvard University), Farnoosh Roohi(Bayer (United States)), Ulrich Dirnagl(German Center for Neurodegenerative Diseases), Randall L. Lindquist(Charité - Universitätsmedizin Berlin), Susanne Mueller(Charité - Universitätsmedizin Berlin), Anna Lena Dätwyler(Stroke Association), Golo Kronenberg(University of Zurich), Frank Wiekhorst(Physikalisch-Technische Bundesanstalt), Lutz Trahms(Physikalisch-Technische Bundesanstalt), Karen Gertz(Humboldt-Universität zu Berlin), Martina Füchtemeier(German Center for Neurodegenerative Diseases), Ulrike Harms(Stroke Association), Andreas Ide(Bayer (United States)), Gunnar Schütz(Bayer (United States)), Matthias Endres(German Center for Neurodegenerative Diseases)
Cited by 32
Related Papers
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Central nervous system injury-induced immune deficiency syndrome
|Nature reviews. Neuroscience|2005|948